Clinical Trial Update: CCR5-modified CD4+ T Cells for HIV Infection [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports completed Phase 1 and Phase 2 studies evaluating CCR5-modified CD4+ T cells for HIV infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• CCR5-modified CD4+ T cells

Snippet

Sponsor: University of Cincinnati | Conditions: HIV Infections | Phase 1, Phase 2 | Status: COMPLETED